Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease
Part of paid clinical trials in Nashville, Tennessee.
- Sponsor
- Toyos Clinic
- Study ID
- NCT06964269
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Autoimmune Diseases
- Dry Eye
- Neurotrophic Keratitis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 85 Years
- Healthy Volunteers
- Accepted
Interventions
- Acthar Gel 80 UNT/ML Injectable Solution — DRUGStudy intervention is twice weekly injections of Acthar Gel via single-dose pre-filled SelfJect injector for 12 weeks.
Study Details
Single-site, open label pilot study of 20 autoimmune patients diagnosed with dry eye demonstrating via the proparacaine challenge some peripheral corneal pain component. At least 16 patients will receive and complete 12 weeks of 80 units of Acthar Gel to be injected subcutaneously twice weekly via Acthar Gel single-dose pre-filled SelfJectTM injector (SelfJect) to assess the effects on subjective sensation of ocular pain, conjunctival and corneal staining, in vivo assessments of corneal nerves as measured by confocal imaging, VAS scales of common neuropathic pain symptoms and comfort of SelfJect will be assessed.
Key Dates
- Start date
- Feb 11, 2025
- Status verified
- May 2025
- Primary completion
- Feb 28, 2028
- Completion
- Feb 28, 2028
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Active Comparator: One study arm of approximately 20 active receiving and completing active, open-label interventions.One study arm of approximately 20 active receiving and completing active, open-label interventions.
Primary Outcome Measure
Visual Analog scale for injection comfort [ Time Frame: 3 years ]
Central Contacts
- Harley cheney Study Coordinator, Study Coordinator+616153274015
- Melissa Toyos, MD, MD6153274015
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Toyos Clinic | Nashville | Tennessee | 37215 | Melissa toyos, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Nashville, TN
By research site
Related Studies
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)Recruiting · Center for International Blood and Marrow Transplant Research · Birmingham, Alabama
- Quality of Life in Presbyopic Patients Who Are Treated With QlosiPHASE4 · Recruiting · Southern College of Optometry · Medina, Minnesota
- An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry EyePHASE2 · Recruiting · Vanda Pharmaceuticals · Newport Beach, California
- Impact of TRYPTYR on a Patient's Quality of Life and Ability to Perform WorkPHASE4 · Recruiting · Southern College of Optometry · Pittsburg, Kansas